NASDAQ:CBIO

Catalyst Biosciences Stock Forecast

etoro logo Buy CBIO
*Your capital is at risk
$17.69
-0.520 (-2.86%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of CBIO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CBIO to Watchlist?
Some Reasons Why To Add CBIO:
  • High gross margin of 100.0%
  • +59.7% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 16.29)
PDF

Catalyst Biosciences stock price ended at $17.69 on Thursday, after losing 2.86%
(Updated on Jun 18, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 03, 2026 Loss -1.61%

The Catalyst Biosciences stock price fell by -2.86% on the last day (Thursday, 18th Jun 2026) from $18.21 to $17.69. During the last trading day the stock fluctuated 6.30% from a day low at $17.30 to a day high of $18.39. The price has fallen in 6 of the last 10 days and is down by -4.12% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -274 thousand shares and in total, 108 thousand shares were bought and sold for approximately $1.91 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.82% during the next 3 months and, with a 90% probability hold a price between $14.54 and $31.88 at the end of this 3-month period.

CBIO Signals & Forecast

There are few to no technical positive signals at the moment. The Catalyst Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.98 and $18.90. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 22, 2026, and so far it has fallen -34.43%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Catalyst Biosciences stock

Catalyst Biosciences finds support from accumulated volume at $17.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.09 between high and low, or 6.30%. For the last week, the stock has had daily average volatility of 5.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CBIO) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Catalyst Biosciences Inc to open at $17.79, and during the day (based on 14 day Average True Range), to move between $16.90 and $18.48, which gives a possible trading interval of +/-$1.58 (+/-9.36%) up or down from last closing price. If Catalyst Biosciences Inc takes out the full calculated possible swing range there will be an estimated 9.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $17.92 (1.30%) than the support at $17.01 (3.87%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Catalyst Biosciences Inc stock A Buy?

The Catalyst Biosciences stock holds several negative signals and despite the positive trend, we believe Catalyst Biosciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.160 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $17.79 ( 0.584%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CBIO Performance

Trading levels for CBIO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 18.88 6.75%
R2 18.47 4.39%
R1 18.21 2.94%
Price 17.69
S1 17.38 -1.77%
S2 17.12 -3.22%
S3 16.70 -5.58%

Accumulated Volume Support & Resistance Levels

Level Price
R3 19.52 10.34%
R2 18.07 2.15%
R1 17.92 1.30%
Price 17.69
S1 17.01 -3.87%
S2 15.16 -14.30%
S3 13.50 -23.69%

CBIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 04, 2023 Jan 13, 2023 Jan 12, 2023 $0.240 38.10%
2 Aug 25, 2022 Sep 21, 2022 Sep 20, 2022 $1.43 73.71%
3 Aug 04, 2015 Aug 20, 2015 Aug 19, 2015 $59.74 25.75%

FAQ

What is the symbol for Catalyst Biosciences Stock and on which exchange is it traded?
The symbol for Catalyst Biosciences is CBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Biosciences Stock?
The Catalyst Biosciences stock holds several negative signals and despite the positive trend, we believe Catalyst Biosciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Catalyst Biosciences Stock?
Catalyst Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Biosciences Stock.

What's the current price of Catalyst Biosciences Stock?
As of the end of day on the Jun 18, 2026, the price of an Catalyst Biosciences (CBIO) share was $17.69.

What is the 52-week high and low for Catalyst Biosciences Stock?
The 52-week high for Catalyst Biosciences Stock is $27.41 and the 52-week low is $8.72.

What is the market capitalization of Catalyst Biosciences Stock?
As of the Jun 18, 2026, the market capitalization of Catalyst Biosciences is 487.747M.

When is the next earnings date for Catalyst Biosciences?
The upcoming earnings date for Catalyst Biosciences is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT CATALYST BIOSCIENCES INC
Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE